2025-07-28 - Analysis Report
Okay, here's an analysis of TG Therapeutics Inc (TGTX) based on the provided data, formatted as a concise English report with key numbers first, followed by analysis.

## TG Therapeutics Inc (TGTX) Analysis

**Company Overview:** TG Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

### 1. Performance vs. S&P 500 (VOO)

*   **TGTX Cumulative Return:** 63.31%
*   **VOO Cumulative Return:** 99.66%
*   **Absolute Deviation:** -36.6%
*   **Relative Deviation:** 14.4%

**Analysis:** TGTX has underperformed the S&P 500 by 36.6% in cumulative returns over the period analyzed. The relative deviation indicates that its current performance is positioned in the lower range of its historical performance relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :----- |
| 2015-2017  | -6.0%  | 56.5%  | -35.0%  | -0.1  | 1.3  |
| 2016-2018  | -8.0%  | 58.6%  | -26.0%  | 0.0   | 0.7  |
| 2017-2019  | 74.0%  | 58.6%  | 44.0%  | 0.0   | 1.8  |
| 2018-2020  | 402.0% | 58.6%  | 382.0% | -0.4  | 8.3  |
| 2019-2021  | 125.0% | 63.5%  | 76.0%  | -0.5  | 3.0  |
| 2020-2022  | -76.0% | 70.4%  | -78.0%  | -0.6  | 1.9  |
| 2021-2023  | -350.0% | 70.4%  | -368.0% | -0.8  | 2.7  |
| 2022-2024  | 71.0%  | 73.1%  | 45.0%  | -0.9  | 4.8  |
| 2023-2025  | 70.0%  | 73.1%  | 19.0%  | 0.4   | 5.9  |

**Analysis:** The table reveals significant volatility in TGTX's performance.
*   **CAGR:** Wide swings in CAGR, from -350% to 402%, indicate high risk.
*   **MDD:** Consistently high Maximum Drawdown values (above 50%) confirm the stock's volatile nature.
*   **Alpha:** A mixed Alpha, with periods of significant outperformance (positive Alpha) and underperformance (negative Alpha) relative to the market.
*   **Beta:** Beta values fluctuating around 0 suggest that the stock's volatility is not strongly correlated with market movements, though some periods show a negative correlation.
*   **Cap(B):** Market capitalization varies, indicating changes in investor valuation.

### 2. Recent Stock Price Movements

*   **Current Price:** $36.90
*   **Previous Close:** $36.53
*   **Change:** 1.01%
*   **5-Day Moving Average:** $37.16
*   **20-Day Moving Average:** $37.22
*   **60-Day Moving Average:** $36.81

**Analysis:** TGTX shows a slight increase in the most recent trading session. The price is currently trading below its 5-day and 20-day moving averages, but above its 60-day moving average, suggesting a potential short-term downtrend but a longer-term stabilizing trend. The recent positive change indicates a small upward momentum.

### 3. Market Risk and Indicators

*   **MRI:** 0.33 (Low Risk)
*   **RSI:** 54.17
*   **PPO:** -0.31
*   **Hybrid Signal:** Cash_70%_Sell (Caution)
*   **Recent Relative Deviation Change (20-day):** -2.7 (downward trend)
*   **Expected Return:** -277.9%

**Analysis:**

*   The Market Risk Indicator (MRI) suggests a low level of market risk currently.
*   The RSI of 54.17 indicates neutral momentum, not overbought or oversold.
*   The negative PPO (-0.31) indicates a slight downtrend.
*   The hybrid signal advising a 70% cash position suggests caution.
*   The negative change in relative deviation indicates a recent underperformance trend compared to the S&P 500.
*   The very negative expected return suggests significant long-term underperformance relative to the S&P 500, which is a major red flag.

### 4. Recent News & Significant Events

*   **2025-07-26:** Business developments, regulatory changes, or market events impacting TGTX.
*   **2025-07-24:** Analyst discussions on TGTX's performance and outlook.
*   **2025-07-27:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-25:** Market experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news snippets indicate recent activity and potential volatility around TGTX, driven by business developments, regulatory changes, analyst opinions, and market reactions. Monitoring these developments is crucial.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
| :--------- | :---- | :--------- |
| 2025-05-09 | 0.03  | 0.12 B$   |
| 2024-11-07 | 0.03  | 0.08 B$   |
| 2024-08-09 | 0.05  | 0.07 B$   |
| 2024-05-06 | -0.07 | 0.06 B$   |
| 2025-05-09 | -0.07 | 0.06 B$   |

**Analysis:** The earnings data shows fluctuating performance. Recent quarters show positive EPS, but earlier data reveals losses. Revenue appears to be increasing, but is still at a relatively low level. The mixed EPS and revenue suggest inconsistent profitability.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
| :--------- | :--------- | :------------ |
| 2025-03-31 | \$0.12B    | 87.14%        |
| 2024-12-31 | \$0.11B    | 85.77%        |
| 2024-09-30 | \$0.08B    | 88.86%        |
| 2024-06-30 | \$0.07B    | 88.70%        |
| 2024-03-31 | \$0.06B    | 91.43%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE      |
| :--------- | :--------- | :------- |
| 2025-03-31 | \$0.24B    | 2.13%    |
| 2024-12-31 | \$0.22B    | 10.49%   |
| 2024-09-30 | \$0.19B    | 2.02%    |
| 2024-06-30 | \$0.18B    | 3.87%    |
| 2024-03-31 | \$0.16B    | -6.69%   |

**Analysis:** Revenue has generally been increasing over the past year. The profit margins are impressively high, indicating efficient cost management or high pricing power. Equity has also been increasing, reflecting growth in the company's net assets. The ROE fluctuates, with a negative value in early 2024 but generally positive values in recent quarters, suggesting improving profitability relative to equity.

### 7. Overall Summary and Assessment

TGTX is a volatile stock with recent underperformance relative to the S&P 500. While revenue and profit margins look strong in recent quarters, the negative expected return and "cash_70%_Sell" hybrid signal indicate significant caution. The stock's recent volatility and the need to monitor news and announcements further emphasize the high-risk nature of this investment. The positive EPS in the recent quarters is a positive sign, but the historical volatility and negative long-term outlook require careful consideration. Investors should exercise caution and conduct thorough due diligence before investing in TGTX.
